{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:07:52Z","timestamp":1794809272653,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00006"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00006"]}]},{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00034"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00034"]}]},{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00034"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00034"]}]},{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00006"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00006"]}]},{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00034"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00034"]}]},{"name":"Ministry of National Economy, Hungary","award":["GINOP-2.3.2-15-2016-00006"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00006"]}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"crossref","award":["OTKA ANN132280"],"award-info":[{"award-number":["OTKA ANN132280"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"crossref","award":["OTKA ANN132280"],"award-info":[{"award-number":["OTKA ANN132280"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"crossref","award":["OTKA ANN132280"],"award-info":[{"award-number":["OTKA ANN132280"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u00daNKP","award":["20391-3\/2018\/FEKUSTRAT"],"award-info":[{"award-number":["20391-3\/2018\/FEKUSTRAT"]}]},{"name":"MTA-SZTE Neuroscience Research Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple sclerosis (MS) and Guillain<jats:bold>\u2013<\/jats:bold>Barr\u00e9 syndrome (GBS) are demyelinating disorders affecting the central nervous system and peripheral nervous system (PNS), respectively. Cerebrospinal fluid (CSF) is one of the most valuable sources of diagnostic biomarkers in neurological diseases. In the present study high sensitivity shotgun mass spectrometry was used to characterise the CSF lipidome of patients with MS, GBS and controls with non-demyelinating diseases. The quantification of 222 CSF lipid molecular species revealed characteristic changes in the absolute and relative lipid concentrations in MS and GBS compared to the controls. For the GBS group, the fourfold elevation in the total lipid content was a discriminatory and a newly identified feature of PNS demyelination. In contrast, in MS, the accumulation of the myelin-derived cerebrosides represented a specific feature of demyelination. As a common feature of demyelination, we identified upregulated levels of lipid metabolic intermediates. We found strong positive correlation between total protein content and lipid concentrations in both diseases. By exploring the CSF lipidome we demonstrate usefulness of broad-range shotgun lipidomic analysis as a fast and reliable method of biomarker discovery in patients with demyelinating neurological disorders that might be a valuable diagnostic complement to existing examinations.<\/jats:p>","DOI":"10.1038\/s41598-020-75502-x","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:03:40Z","timestamp":1603796620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"M\u00e1ria","family":"P\u00e9ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Petrovics-Balog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00edgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"75502_CR1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet (Lond. Engl.) 372, 1502\u20131517 (2008).","journal-title":"Lancet (Lond. Engl.)"},{"key":"75502_CR2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/B978-0-444-64076-5.00046-6","volume":"148","author":"C Cotsapas","year":"2018","unstructured":"Cotsapas, C., Mitrovic, M. & Hafler, D. Multiple sclerosis. Handb. Clin. Neurol. 148, 723\u2013730 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"75502_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg, B. et al. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10, 469\u2013482 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"75502_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","volume":"92","author":"EFM Wijdicks","year":"2017","unstructured":"Wijdicks, E. F. M. & Klein, C. J. Guillain-Barr\u00e9 syndrome. Mayo Clin. Proc. 92, 467\u2013479 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"75502_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00207454.2014.913588","volume":"125","author":"S Dash","year":"2015","unstructured":"Dash, S., Pai, A. R., Kamath, U. & Rao, P. Pathophysiology and diagnosis of Guillain-Barr\u00e9 syndrome-challenges and needs. Int. J. Neurosci. 125, 235\u2013240 (2015).","journal-title":"Int. J. Neurosci."},{"key":"75502_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh, S., Abdelhak, A., Foschi, M., Tumani, H. & Otto, M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10124-x (2020).","journal-title":"J. Neurol."},{"key":"75502_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","volume":"58","author":"ND Lawn","year":"2001","unstructured":"Lawn, N. D., Fletcher, D. D., Henderson, R. D., Wolter, T. D. & Wijdicks, E. F. M. Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome. Arch. Neurol. 58, 893 (2001).","journal-title":"Arch. Neurol."},{"key":"75502_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/ijms18020353","volume":"18","author":"C Rajda","year":"2017","unstructured":"Rajda, C., Pukoli, D., Bende, Z., Majl\u00e1th, Z. & V\u00e9csei, L. Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis. Int. J. Mol. Sci. 18, 353 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"75502_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molmed.2017.01.004","volume":"23","author":"A Iwasaki","year":"2017","unstructured":"Iwasaki, A. Immune regulation of antibody access to neuronal tissues. Trends Mol. Med. 23, 227\u2013245 (2017).","journal-title":"Trends Mol. Med."},{"key":"75502_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2012-302312","volume":"84","author":"T Kanda","year":"2013","unstructured":"Kanda, T. Biology of the blood\u2013nerve barrier and its alteration in immune mediated neuropathies. J. Neurol. Neurosurg. Psychiatry 84, 208\u2013212 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"75502_CR11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","volume":"45","author":"GG Ortiz","year":"2014","unstructured":"Ortiz, G. G. et al. Role of the blood-brain barrier in multiple sclerosis. Arch. Med. Res. 45, 687\u2013697 (2014).","journal-title":"Arch. Med. Res."},{"key":"75502_CR12","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299\u20133305 (2010).","journal-title":"J. Lipid Res."},{"key":"75502_CR13","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1194\/jlr.M079012","volume":"58","author":"JA Bowden","year":"2017","unstructured":"Bowden, J. A. et al. Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in frozen human plasma. J. Lipid Res. 58, 2275\u20132288 (2017).","journal-title":"J. Lipid Res."},{"key":"75502_CR14","volume-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","author":"P Morell","year":"2006","unstructured":"Morell, P. & Quarles, R. H. Myelin formation, structure and biochemistry. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects (eds George, J. S. et al.) (Elsevier Academic Press, Amsterdam, 2006)."},{"key":"75502_CR15","doi-asserted-by":"crossref","unstructured":"Naud\u00ed, A. et al. Lipidomics of human brain aging and Alzheimer\u2019s disease pathology. In International Review of Neurobiology 122, 133\u2013189 (Academic Press Inc., 2015).","DOI":"10.1016\/bs.irn.2015.05.008"},{"key":"75502_CR16","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","volume":"287","author":"RB Chan","year":"2012","unstructured":"Chan, R. B. et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J. Biol. Chem. 287, 2678\u20132688 (2012).","journal-title":"J. Biol. Chem."},{"key":"75502_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-141602908-3.50013-3","volume-title":"Cerebrospinal Fluid in Clinical Practice","author":"D Irani","year":"2009","unstructured":"Irani, D. Properties and composition of normal cerebrospinal fluid. In Cerebrospinal Fluid in Clinical Practice (ed. Irani, D.) 69\u201389 (Elsevier Inc., Amsterdam, 2009)."},{"key":"75502_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1466","author":"VB O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, V. B., Ekroos, K., Liebisch, G. & Wakelam, M. lipidomics: current state of the art in a fast moving field. Wiley Interdiscip. Rev. Syst. Biol. Med. https:\/\/doi.org\/10.1002\/wsbm.1466 (2019).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"75502_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10545-014-9798-0","volume":"38","author":"B Colsch","year":"2014","unstructured":"Colsch, B., Seyer, A., Boudah, S. & Junot, C. Lipidomic analysis of cerebrospinal fluid by mass spectrometry\u2013based methods. J. Inherit. Metab. Dis. 38, 53\u201364 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"75502_CR20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1194\/jlr.D076588","volume":"58","author":"M Blomqvist","year":"2017","unstructured":"Blomqvist, M. et al. High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS\/MS. J. Lipid Res. 58, 1482\u20131489 (2017).","journal-title":"J. Lipid Res."},{"key":"75502_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","volume":"27","author":"PL Wood","year":"2015","unstructured":"Wood, P. L., Barnette, B. L., Kaye, J. A., Quinn, J. F. & Woltjer, R. L. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer\u2019s disease subjects. Acta Neuropsychiatr. 27, 270\u2013278 (2015).","journal-title":"Acta Neuropsychiatr."},{"key":"75502_CR22","doi-asserted-by":"crossref","first-page":"e0125597","DOI":"10.1371\/journal.pone.0125597","volume":"10","author":"AN Fonteh","year":"2015","unstructured":"Fonteh, A. N. et al. Sphingolipid metabolism correlates with cerebrospinal fluid beta amyloid levels in Alzheimer\u2019s disease. PLoS ONE 10, e0125597 (2015).","journal-title":"PLoS ONE"},{"key":"75502_CR23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson, M. et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57, 897\u2013902 (1994).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"75502_CR24","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/gb-2011-12-1-r8","volume":"12","author":"R Herzog","year":"2011","unstructured":"Herzog, R. et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol. 12, R8 (2011).","journal-title":"Genome Biol."},{"key":"75502_CR25","doi-asserted-by":"crossref","first-page":"01","DOI":"10.13188\/2332-3469.1000035","volume":"5","author":"S Dasgupta","year":"2017","unstructured":"Dasgupta, S. & Swapan, K. R. Diverse biological functions of sphingolipids in the CNS: ceramide and sphingosine regulate myelination in developing brain but stimulate demyelination during pathogenesis of multiple sclerosis. J. Neurol. Psychol. 5, 01\u201307 (2017).","journal-title":"J. Neurol. Psychol."},{"key":"75502_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08314-1","volume":"7","author":"G Capodivento","year":"2017","unstructured":"Capodivento, G. et al. Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies. Sci. Rep. 7, 1\u20139 (2017).","journal-title":"Sci. Rep."},{"key":"75502_CR27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458514561908","volume":"21","author":"A Checa","year":"2015","unstructured":"Checa, A. et al. Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Mult. Scler. 21, 1271\u20131279 (2015).","journal-title":"Mult. Scler."},{"key":"75502_CR28","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1038\/s41598-019-47906-x","volume":"9","author":"L Nogueras","year":"2019","unstructured":"Nogueras, L. et al. Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis. Sci. Rep. 9, 11313 (2019).","journal-title":"Sci. Rep."},{"key":"75502_CR29","doi-asserted-by":"crossref","first-page":"e0166277","DOI":"10.1371\/journal.pone.0166277","volume":"11","author":"SJ Park","year":"2016","unstructured":"Park, S. J. et al. Disease type- and status-specific alteration of CSF metabolome coordinated with clinical parameters in inflammatory demyelinating diseases of CNS. PLoS ONE 11, e0166277 (2016).","journal-title":"PLoS ONE"},{"key":"75502_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"SJ Park","year":"2019","unstructured":"Park, S. J. et al. Integrative metabolomics reveals unique metabolic traits in Guillain-Barr\u00e9 Syndrome and its variants. Sci. Rep. 9, 1\u201314 (2019).","journal-title":"Sci. Rep."},{"key":"75502_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-016-0564-9","volume":"16","author":"SM LeVine","year":"2016","unstructured":"LeVine, S. M. Albumin and multiple sclerosis. BMC Neurol. 16, 47 (2016).","journal-title":"BMC Neurol."},{"key":"75502_CR32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","volume":"252","author":"J Brettschneider","year":"2005","unstructured":"Brettschneider, J., Claus, A., Kassubek, J. & Tumani, H. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J. Neurol. 252, 1067\u20131073 (2005).","journal-title":"J. Neurol."},{"key":"75502_CR33","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/brain\/awu139","volume":"137","author":"OG Vidaurre","year":"2014","unstructured":"Vidaurre, O. G. et al. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain 137, 2271\u20132286 (2014).","journal-title":"Brain"},{"key":"75502_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-3639.2011.00501.x","volume":"22","author":"S Kim","year":"2012","unstructured":"Kim, S., Steelman, A. J., Zhang, Y., Kinney, H. C. & Li, J. Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol. 22, 41\u201357 (2012).","journal-title":"Brain Pathol."},{"key":"75502_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R Van Doorn","year":"2012","unstructured":"Van Doorn, R. et al. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol. 124, 397\u2013410 (2012).","journal-title":"Acta Neuropathol."},{"key":"75502_CR36","doi-asserted-by":"crossref","first-page":"e0178622","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami, M. et al. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS ONE 12, e0178622 (2017).","journal-title":"PLoS ONE"},{"key":"75502_CR37","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11064-017-2280-2","volume":"42","author":"LG Miller","year":"2017","unstructured":"Miller, L. G. et al. Sphingosine toxicity in EAE and MS: evidence for ceramide generation via serine-palmitoyltransferase activation. Neurochem. Res. 42, 2755\u20132768 (2017).","journal-title":"Neurochem. Res."},{"key":"75502_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-2275(20)30182-6","volume":"43","author":"PU Huey","year":"2002","unstructured":"Huey, P. U., Waugh, K. C., Etienne, J. & Eckel, R. H. Lipoprotein lipase is expressed in rat sciatic nerve and regulated in response to crush injury. J. Lipid Res. 43, 19\u201325 (2002).","journal-title":"J. Lipid Res."},{"key":"75502_CR39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnmol.2018.00057","volume":"11","author":"KD Bruce","year":"2018","unstructured":"Bruce, K. D. et al. Lipoprotein lipase is a feature of alternatively-activated microglia and may facilitate lipid uptake in the CNS during demyelination. Front. Mol. Neurosci. 11, 57 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"75502_CR40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3389\/fimmu.2019.00950","volume":"10","author":"A Kamermans","year":"2019","unstructured":"Kamermans, A. et al. Reduced angiopoietin-like 4 expression in multiple sclerosis lesions facilitates lipid uptake by phagocytes via modulation of lipoprotein-lipase activity. Front. Immunol. 10, 950 (2019).","journal-title":"Front. Immunol."},{"key":"75502_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2015.01.001","volume":"36","author":"MA Frohman","year":"2015","unstructured":"Frohman, M. A. The phospholipase D superfamily as therapeutic targets. Trends Pharmacol. Sci. 36, 137\u2013144 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"75502_CR42","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1101\/gad.1638008","volume":"22","author":"K Nadra","year":"2008","unstructured":"Nadra, K. et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22, 1647\u20131661 (2008).","journal-title":"Genes Dev."},{"key":"75502_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/acscentsci.7b00367","volume":"4","author":"MS Bergholt","year":"2018","unstructured":"Bergholt, M. S. et al. Correlated Heterospectral lipidomics for biomolecular profiling of remyelination in multiple sclerosis. ACS Cent. Sci. 4, 39\u201351 (2018).","journal-title":"ACS Cent. Sci."},{"key":"75502_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(80)90201-4","volume":"48","author":"KJ Smith","year":"1980","unstructured":"Smith, K. J. & Hall, S. M. Nerve conduction during peripheral demyelination and remyelination. J. Neurol. Sci. 48, 201\u2013219 (1980).","journal-title":"J. Neurol. Sci."},{"key":"75502_CR45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4161\/bioe.22835","volume":"4","author":"RP Murphy","year":"2013","unstructured":"Murphy, R. P., Murphy, K. J. & Pickering, M. The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges. Bioengineered 4, 140\u2013146 (2013).","journal-title":"Bioengineered"},{"key":"75502_CR46","first-page":"215","volume":"47","author":"SK Ludwin","year":"1988","unstructured":"Ludwin, S. K. Remyelination in the central nervous system and the peripheral nervous system. Adv. Neurol. 47, 215\u2013254 (1988).","journal-title":"Adv. Neurol."},{"key":"75502_CR47","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1038\/s41598-017-08338-7","volume":"7","author":"H-Y Tang","year":"2017","unstructured":"Tang, H.-Y. et al. disturbance of plasma lipid metabolic profile in Guillain-Barre syndrome. Sci. Rep. 7, 8140 (2017).","journal-title":"Sci. Rep."},{"key":"75502_CR48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"75502_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke, C. et al. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137, 33\u201343 (2014).","journal-title":"Brain"},{"key":"75502_CR50","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen, C. E. et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73, 1914\u20131922 (2009).","journal-title":"Neurology"},{"key":"75502_CR51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497\u2013509 (1957).","journal-title":"J Biol Chem"},{"key":"75502_CR52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"75502_CR53","doi-asserted-by":"crossref","first-page":"e0173739","DOI":"10.1371\/journal.pone.0173739","volume":"12","author":"M P\u00e9ter","year":"2017","unstructured":"P\u00e9ter, M. et al. Metabolic crosstalk between membrane and storage lipids facilitates heat stress management in Schizosaccharomyces pombe. PLoS ONE 12, e0173739 (2017).","journal-title":"PLoS ONE"},{"key":"75502_CR54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5, 1005\u20131018 (2010).","journal-title":"Nat. Protoc."},{"key":"75502_CR55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1194\/jlr.M033506","volume":"54","author":"G Liebisch","year":"2013","unstructured":"Liebisch, G. et al. Shorthand notation for lipid structures derived from mass spectrometry. J. Lipid Res. 54, 1523\u20131530 (2013).","journal-title":"J. Lipid Res."},{"key":"75502_CR56","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/03610918.2017.1353613","volume":"47","author":"H Luepsen","year":"2018","unstructured":"Luepsen, H. Comparison of nonparametric analysis of variance methods: A vote for van der Waerden. Commun. Stat. Simul. Comput. 47, 2547\u20132576 (2018).","journal-title":"Commun. Stat. Simul. Comput."},{"key":"75502_CR57","first-page":"101","volume":"25","author":"A Vargha","year":"2000","unstructured":"Vargha, A. & Delaney, H. D. A critique and Improvement of the CL common language effect size statistics of McGraw and Wong. J. Educ. Behav. Stat. 25, 101\u2013132 (2000).","journal-title":"J. Educ. Behav. Stat."},{"key":"75502_CR58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00273171.2012.658329","volume":"47","author":"J Ruscio","year":"2012","unstructured":"Ruscio, J. & Mullen, T. Confidence Intervals for the probability of superiority effect size measure and the area under a receiver operating characteristic curve. Multivariate Behav. Res. 47, 201\u2013223 (2012).","journal-title":"Multivariate Behav. Res."},{"key":"75502_CR59","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S. A. 100, 9440\u20139445 (2003).","journal-title":"Proc. Natl. Acad. Sci. U.S. A."},{"key":"75502_CR60","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (2020). Available at: https:\/\/www.r-project.org."},{"key":"75502_CR61","first-page":"1","volume":"55","author":"J Xia","year":"2016","unstructured":"Xia, J. & Wishart, D. S. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr. Protoc. Bioinforma. 55, 1\u201391 (2016).","journal-title":"Curr. Protoc. Bioinforma."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75502-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75502-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75502-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:21:42Z","timestamp":1670365302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75502-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75502-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18380"}}